Status:
COMPLETED
Phase 1 Food Effect Study for Alicaforsen Tablets
Lead Sponsor:
Atlantic Pharmaceuticals Ltd
Conditions:
IBD
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
Phase 1 study to compare the effect of food on alicaforsen tablet.
Detailed Description
A study on healthy male vounteers in a phase 1 unit. Alicaforsen tablets are gievn in a fed and fasted state
Eligibility Criteria
Inclusion
- Healthy Volunteer
Exclusion
- Drugs of abuse
- Alcohol abuse
Key Trial Info
Start Date :
March 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03473626
Start Date
March 16 2018
End Date
April 6 2018
Last Update
November 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phase 1 unit
Nottingham, United Kingdom